Gene Therapy with P53 and a Fragment of Thrombospondin I Inhibits Human Breast Cancerin Vivo
- 28 February 1998
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 63 (2) , 103-109
- https://doi.org/10.1006/mgme.1997.2654
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Parenteral Gene Therapy with p53 Inhibits Human Breast TumorsIn VivoThrough a Bystander Mechanism Without Evidence of ToxicityHuman Gene Therapy, 1997
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- Angiostatin induces and sustains dormancy of human primary tumors in miceNature Medicine, 1996
- Systemic Gene Therapy with p53 Reduces Growth and Metastases of a Malignant Human Breast Cancer in Nude MiceHuman Gene Therapy, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutantNature, 1994
- Site-Specific Gene Expression in Vivo by Direct Gene Transfer into the Arterial WallScience, 1990
- Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB GeneScience, 1990
- Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related PeptidesScience, 1990